The Role of Biofield Energy Treated DMEM in Erectile
Dysfunction using Detection of Cgmp Levels in Human
Endothelial Cell Line
Volume 3 - Issue 1
Mahendra Kumar Trivedi1 and Snehasis Jana2*
-
Author Information
Open or Close
- 1Trivedi Global, Inc., Henderson, USA
- 2Trivedi Science Research Laboratory Pvt. Ltd., India
*Corresponding author:
Snehasis Jana, Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India
Received: January 28, 2019 Published: February 04, 2019
DOI: 10.32474/OAJBEB.2019.03.000154
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
The study was performed to assess the impact of Biofield Treated test item (DMEM medium) on Human Endothelial Hybrid
Cell Line (EA. hy926) for the expression of cyclic guanosine monophosphate (cGMP). The test item was divided into three parts.
The first part was received one-time Consciousness Energy Treatment by a renowned Biofield Energy Healer, Mahendra Kumar
Trivedi and labeled as BT-I, while second part received two-times Biofield Treatment and is denoted as BT-II. The third part did
not receive any types of treatment and denoted as untreated DMEM. The level of intracellular cGMP in the BT-I and BT-II groups
showed a significantly (p≤0.001) increased by 296.06% and 339.37%, respectively in Ea. hy926 cells compared to the untreated
DMEM group. These results suggest that BT-II group showed a significant improved the level of cGMP with respect to the BT-I group.
Therefore, the Biofield Energy Healing Treatment can be used to treat the erectile dysfunction patients along with other associated
disorders such as orgasmic disorders, frotteuristic disorder, female sexual arousal disorder, vaginismus, fetishistic disorder, sex
addiction, hypoactive sexual desire disorder, premature or delayed ejaculation.
Keywords: Biofield Energy; cGMP; Endothelial Hybrid Cell; PDE-5; DMEM; Erectile Dysfunction
Abbreviation: BT-I: One-time Biofield Energy Treated DMEM; BT-II: Two-times Biofield Energy Treated DMEM; CAM:
Complementary and Alternative Medicine; NCCAM: National Center for Complementary and Alternative Medicine; DMEM:
Dulbecco’s Modified Eagle’s Medium; cGMP: Cyclic guanosine 3′,5′-monophosphate; FBS: Fetal Bovine Serum
Abstract|
Introduction|
Material and Methods|
Result and Discussion|
Conclusion|
References|